Minister Of Health Assigns RSCM To Be A Manpowerer Of Regional Hospitals Handling Diabetes

The signing process for the collaboration between RSCM Jakarta and the Joslin Diabetes Center which was held in Jakarta on Friday (14/7/2023). ANTARA/HO-Kemenkes

JAKARTA - Health Minister Budi Gunadi Sadikin appointed the Cipto Mangunkusumo Hospital (RSCM) Jakarta to manage hospitals in the regions to treat patients with diabetes.

RSCM has the task of being a national fit for diabetes because diabetes is the mother of all diseases (mothers of all diseases). So, if you have diabetes, it can affect other diseases such as kidney, heart disease, and stroke," said Minister of Health Budi as quoted by ANTARA, Saturday, July 15.

The Minister of Health said that to be able to be a manager for other hospitals, RSCM as a vertical hospital under the auspices of the Ministry of Health (Kemenkes), collaborated with the American Joslin Diabetes Center to increase capacity as a treatment hospital for diabetes services since 2022.

"The task of RSCM is to ensure that we can arrange a service network starting from the lowest at the puskesmas level to the highest at the hospital level. The target is only one, namely reducing the death of Indonesians from diabetes," said the Minister of Health.

Plt. President Director of RSCM Lies Dina Liastuti said that RSCM is currently asked to be able to serve diabetes in patients in an integrated manner. This collaboration is considered to increase the capacity of human resources at RSCM in order to be able to manage other hospitals in the regions for diabetes services.

"If we are able to be at their level, we will teach other hospitals. The Joslin Diabetes Center will visit the Diabetes Center Clinic at the RSCM, they will see if there is any action in the construction of the service flow, then the lack of equipment we have, and so on. what recommendations do we have to fix," he said.

Interim Chief Medical Officer and Senior Vice President Joslin Diabetes Center Sanjeev Mehta said that for almost six months his party had held discussions to understand the management and treatment of diabetes in Indonesia, especially through the RSCM perspective.

"Through the assessment phase, it aims to understand the operational clinicality related to diabetes management throughout Indonesia, especially related to the treatment provided by the RSCM, the self-assessment process will last until September," he said.

After this assessment is completed, Joslin will provide the best practice recommendations for providing advanced therapy for diabetes. After this assessment phase and comprehensive submission of recommendations, Indonesia will be offered the opportunity to participate in phase two, namely implementation. "So we are currently starting phase one, which is an in-depth assessment to really understand the management of diabetes treatment in Indonesia, assuming that what we are doing (the diabetes treatment) in Boston makes sense to implement in Indonesia," said Mehta.